Related Experiment Video
Updated: Oct 16, 2025

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
Published on: August 7, 2017
Intrapartum antibiotics and childhood asthma and allergic rhinitis: a retrospective cohort study
M Richards1, J Ferber2, E Swor3
1School of Public Health, University of Nevada, Reno, NV, USA.
Insights
Intrapartum antibiotics (IABX) exposure is not a strong predictor of childhood asthma or allergic rhinitis. This retrospective cohort study found minimal association between IABX and these common childhood conditions.
Area of Science:
- Pediatric Allergy and Immunology
- Obstetrics and Gynecology
- Public Health Research
Background:
- Intrapartum antibiotics (IABX) use has increased significantly.
- Potential links between IABX and childhood allergic diseases require investigation.
Purpose of the Study:
- To evaluate the association between intrapartum antibiotic exposure and the development of asthma and allergic rhinitis in children.
- To assess these associations at ages 6, 8, and 10 years.
Main Methods:
- Retrospective cohort study utilizing data from Kaiser Permanente Northern California.
- Modified Poisson regressions were used to estimate risk ratios for IABX and outcomes.
- Analysis covered two birth cohorts: 1997-2004 and 2005-2012.
Main Results:
- IABX use rose from 4% in 1997 to 49% in 2011, while asthma and allergic rhinitis incidence remained stable.
- Risk ratios for asthma and allergic rhinitis associated with IABX were generally close to the null.
- Slightly elevated risk ratios were observed in some analyses, particularly for asthma in the later cohort.
Conclusions:
- Intrapartum antibiotic exposure does not appear to be a significant predictor of childhood asthma or allergic rhinitis.
- Further research may explore subtle associations or specific subgroups.
Objective:
This study aimed to evaluate the association between intrapartum antibiotics (IABX) and asthma and allergic rhinitis among children by ages 6, 8 and 10 years.
Design:
Retrospective cohort.
Setting And Population:
Data were collected though Kaiser Permanente Northern California's (KPNC) integrated healthcare system. Children were eligible if they were born in a KPNC hospital between 1997 and 2012 and stayed enrolled through age 6.
Methods:
Modified Poisson regressions with robust error variances were used to estimate risk ratios for IABX and each outcome at each follow-up age during two separate time periods: 1997-2004 (n = 91 739) and 2005-2012 (n = 108 314).
Main Outcome Measures:
Asthma and allergic rhinitis by ages 6, 8 and 10.
Results:
The proportion of women receiving IABX increased drastically over the study period (from 4% in 1997 to 49% in 2011), while the incidence of asthma (8%) and allergic rhinitis (6%) stayed relatively stable. In adjusted models, risk ratios for the association between IABX and asthma and allergic rhinitis were largely compatible with the null, with some slightly elevated risk ratios observed. For births from 1997 to 2004, risk ratios for asthma were 1.08 (95% CI 1.00-1.17) at age 6, 1.05 (95% CI 0.97-1.15) at age 8, and 1.08 (95% CI 0.99-1.18) at age 10. For births from 2005 to 2012, risk ratios were 1.00 (95% CI 0.95-1.04) at age 6, 1.07 (95% CI 1.01-1.12) at age 8, and 1.11 (95% CI 1.03-1.20) at age 10.
Conclusions:
Exposure to intrapartum antibiotics is not a strong predictor of childhood asthma or allergic rhinitis risk.
Tweetable Abstract:
Exposure to intrapartum antibiotics is not a strong predictor of childhood asthma or allergic rhinitis risk.
More Related Videos
11:54Absorption of Nasal and Bronchial Fluids: Precision Sampling of the Human Respiratory Mucosa and Laboratory Processing of Samples
Published on: January 21, 2018
03:40Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis
Published on: December 20, 2024
Related Concept Videos
Asthma-I: Introduction
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...